Skip to main content
CON
NYSE Life Sciences

Q3 Revenue Up 8.6%, EPS Up 37%; FY26 Guidance Raised and New $250M Buyback Authorized

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$41.906
Mkt Cap
$5.375B
52W Low
$18.545
52W High
$44.22
52W Position info
126% above low
Off High info
5.2% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

CON has more than doubled off its 52-week low of $18.545.

Summary

Concentra beat its own trajectory with Q3 revenue of $622.1 million, up 8.6% year over year, and EPS of $0.52, up 36.8%. Adjusted EBITDA rose 17.9% to $140.2 million, expanding margin to 22.5% from 20.8%. The company raised full-year 2026 guidance to revenue of $2.360-$2.380 billion and Adjusted EBITDA of $505-$510 million, and authorized a new $250 million buyback on top of its existing program. It also declared a $0.0625 quarterly dividend and got an S&P upgrade to BB with Moody's outlook moved to positive. This is the first quarter under new CEO Matt DiCanio, who took over November 1 from Keith Newton, now executive chairman. Q3 free cash flow of $32.2 million came in below last year's $40.2 million on higher working capital use, a soft spot worth noting. The earnings call is November 6 at 9 a.m. ET.

At the time of this announcement, CON was trading at $41.91 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $18.55 to $44.22. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

CON - Latest Insights

CON
Nov 05, 2026, 5:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.99
Real-time Price: $41.99 info
Change: $0 (0%) info
Market Cap: $5.375B info
CON
Nov 05, 2026, 4:36 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.00
Real-time Price: $41.99 info
Change: -$0.0100 (-0.02%) info
Market Cap: $5.375B info
CON
Aug 24, 2026, 4:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $34.99
Real-time Price: $41.99 info
Change: +$7.00 (+20%) info
Market Cap: $5.375B info
CON
Aug 06, 2026, 5:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.54
Real-time Price: $41.99 info
Change: +$11.45 (+37%) info
Market Cap: $5.375B info
CON
Aug 06, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.54
Real-time Price: $41.99 info
Change: +$11.45 (+37%) info
Market Cap: $5.375B info